Ken Griffin's position in 10x Genomics is currently worth $3.31 Million. That's 0.00% of their equity portfolio (1813th largest holding). The first 10x Genomics trade was made in Q3 2019. Since then Ken Griffin bought shares seven more times and sold shares on nine occasions. The investor's estimated purchase price is $4.09 Million, resulting in a loss of 19%.